Best printers for Home

Best Mixer Grinder

Best wired Earphones

Best 43 Inch TV in India

Best Wi Fi Routers

Best Home Theatre in India

Smart Watch under 5000

Best Laptops for Education

Best Laptop for Students

As many as 290 cases of <keyword id="21545939" type="General" weightage="20" keywordseo="KP-2" source="keywords">KP.2</keyword> and 34 cases of <keyword id="21748081" type="General" weightage="20" keywordseo="KP-1" source="keywords">KP.1</keyword>, both sub-lineages of COVID-19 that are responsible for surge in cases in Singapore, have been found in India, according to official data. However, a source in the Union health ministry told PTI that they are all sub variants of <keyword id="20115417" type="General" weightage="20" keywordseo="JN1" source="keywords">JN1</keyword> and there is no associated increase in hospitalisation and severe cases. "So there is no reason for concern or panic. The mutations will keep happening at a rapid pace and this is the natural behaviour of viruses like SARS-CoV2," the source said. The source further said that the INSACOG surveillance is sensitive and is able to pick up the emergence of any new variant and samples are also picked from hospitals in a structured manner to detect any change in the severity of disease due to virus. Data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed that 34 cases of KP.1 have been found across seven states and UTs with 23 cases registered from West Bengal. The other states are Goa (1), Gujarat (2), Haryana (1), Maharashtra (4) Rajasthan (2) and Uttarakhand (1). As many as 290 cases of KP.2 have been registered with Maharashtra reporting the highest number at 148, according to the data. The other states and Union territories are Delhi (1), Goa (12), Gujarat (23), Haryana (3), Karnataka (4), Madhya Pradesh (1), Odisha (17), Rajasthan (21), Uttar Pradesh (8), Uttarakhand (16) and West Bengal (36). Singapore is seeing a new COVID-19 wave as the authorities recorded more than 25,900 cases from May 5 to 11 with KP.1 and KP.2 accounting for over two-thirds of cases in Singapore. Globally, the predominant COVID-19 variants are still JN.1 and its sub-lineages, including KP.1 and KP.2. KP.1 and KP.2 belong to a group of COVID-19 variants scientists have nicknamed 'FLiRT', after the technical names of their mutations. The strains in FLiRT are all descendants of the JN.1 variant, an offshoot of the Omicron variant. KP.2 was classified by the World Health Organization as a Variant Under Monitoring.

290 cases of COVID-19 variant KP.2, 34 cases of KP.1 detected in India: INSACOG data

Geneva [Switzerland], August 19 (ANI): World Health Organization (WHO) designated <keyword id="18456567" type="General" weightage="20" keywordseo="covid-19-variant-ba-2-86" source="Orion">COVID-19 variant BA.2.86</keyword> as a 'variant under monitoring' due to the large number of mutations it carries. The WHO said on Friday that they are tracking 3 variants of interest and 7 variants under monitoring at the moment. "WHO continues to call for better surveillance, sequencing, and reporting of #COVID19 as this virus continues to circulate and evolve," the WHO said in a tweet. Who further stated that it needed more data to understand this COVID19 variant and the extent of its spread, but the number of mutations warrants attention. Recently, the latest variant, EG.5 (also known as Eris), has grabbed the attention of public health experts around the world and is becoming a dominant strain in countries including the United States and Britain. The variant is causing about 17 per cent of the new Covid-19 cases in the country compared to 16 per cent for the next most common lineage, XBB.1.16, according to the latest estimates from the US Centers for Disease Control and Prevention, CNN reported. The new variant is a spinoff of the XBB recombinant strain of the Omicron family. According to the WHO, all viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no impact on the virus's properties. However, some changes may affect the virus's properties, such as how easily it spreads, the associated disease severity, or the performance of vaccines, therapeutic medicines, diagnostic tools, or other public health and social measures. In June 2020, the WHO Virus Evolution Working Group was established with a specific focus on SARS-CoV-2 variants, their phenotype and their impact on countermeasures. This later became the Technical Advisory Group on SARS-CoV-2 Virus Evolution. In late 2020, the emergence of variants that posed an increased risk to global public health prompted WHO to characterize some as variants of interest (VOIs) and variants of concern (VOCs) to prioritize global monitoring and research and to inform and adjust the COVID-19 response. From May 2021 onwards, WHO began assigning simple, easy-to-say labels for key variants. Considerable progress has been made in establishing and strengthening a global system to detect signals of potential VOIs or VOCs and rapidly assess the risk posed by SARS-CoV-2 variants to public health. It remains critical that these systems are maintained, and data are shared, according to good principles and in a timely fashion, as SARS-CoV-2 continues to circulate at high levels around the world. While monitoring the circulation of SARS-CoV-2 globally, it also remains essential to monitor their spread in animal populations and chronically infected individuals, which are crucial aspects of the global strategy to reduce the occurrence of mutations that have negative public health implications. In March 2023, WHO updated its tracking system and working definitions for variants of concern, variants of interest and variants under monitoring, as per WHO. (ANI)

WHO designates Covid's BA.2.86 as 'variant under monitoring'

<keyword id="19895045" type="General" weightage="20" keywordseo="Singapore" source="keywords">Singapore</keyword> is seeing a new <keyword id="21710881" type="General" weightage="20" keywordseo="Covid-19-wave" source="keywords">COVID-19 wave</keyword> as the authorities recorded more than 25,900 cases from May 5 to 11 even as <keyword id="19962428" type="General" weightage="20" keywordseo="Health-Minister" source="keywords">Health Minister</keyword> <keyword id="19895083" type="General" weightage="20" keywordseo="Ong-Ye-Kung" source="keywords">Ong Ye Kung</keyword> on Saturday advised the wearing of masks again. "We are at the beginning part of the wave where it is steadily rising," said Ong. "So, I would say the wave should peak in the next two to four weeks, which means between mid- and end of June," The Straits Times newspaper quoted the minister as saying. The Ministry of Health (MOH) said the estimated number of COVID-19 cases in the week of May 5 to 11 rose to 25,900 cases, compared with 13,700 cases in the previous week. The average daily COVID-19 hospitalisations rose to about 250 from 181 the week before. The average daily intensive care unit (ICU) cases remained low at three cases, compared with two cases in the previous week. The MOH said that to protect hospital bed capacity, public hospitals have been asked to reduce their non-urgent elective surgery cases and move suitable patients to transitional care facilities or back home through Mobile Inpatient Care@Home, an alternative inpatient care delivery model that offers clinically suitable patients the option of being hospitalised in their own homes instead of a hospital ward. Ong urged those who are at greatest risk of severe disease, including individuals aged 60 years and above, medically vulnerable individuals and residents of aged care facilities, to receive an additional dose of the COVID-19 vaccine if they have not done so in the last 12 months. Ong said that if the number of COVID-19 cases doubles one time, Singapore will have 500 patients in its healthcare system, which is what Singapore can handle. However, if the number of cases doubles a second time, there will be 1,000 patients, and "that will be a considerable burden on the hospital system", he pointed out. "One thousand beds is equivalent to one regional hospital," Ong said. "So, I think the healthcare system has to brace ourselves for what is to come." There are no plans for any form of social restrictions or any other mandatory kind of measures for now, as COVID-19 is treated as an endemic disease in Singapore, he said, adding that imposing additional measures would be a last resort. Ong said that with Singapore being a transport and communications hub, it will be one of the cities to get a wave of COVID-19 earlier than others. "So, COVID-19 is just something that we have to live with. Every year, we should expect one or two waves," he said. Globally, the predominant COVID-19 variants are still JN.1 and its sub-lineages, including KP.1 and KP.2. Currently, KP.1 and KP.2 account for over two-thirds of cases in Singapore. As of May 3, the World Health Organisation has classified KP.2 as a variant under monitoring. There are currently no indications, globally or locally, that KP.1 and KP.2 are more transmissible or cause more severe disease than other circulating variants, the MOH said. However, members of the public are urged to stay updated with vaccinations to protect themselves against current and emerging virus strains. The MOH said that to date, about 80 per cent of the local population have completed their initial or additional dose, but have not received a dose within the last year. The ministry added that since COVID-19 vaccination started in 2020 to 2021, the vaccines have consistently been proven to be safe and effective in protecting individuals from severe illness. Billions of doses have been administered globally, and safety monitoring internationally has shown that the vaccine is safe, it said. There have also been no long-term safety concerns with COVID-19 vaccination, and adverse effects from vaccines, including the mRNA vaccines, have all been observed to occur shortly after vaccination, the ministry added. SEE ALSO:<a href="https://www.businessinsider.in/tech/mobile/webstories/motorola-edge-50-fusion-vs-oneplus-nord-ce-4-price-specs-and-features-compared/slidelist/110197390.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/mobile/webstories/motorola-edge-50-fusion-vs-oneplus-nord-ce-4-price-specs-and-features-compared/slidelist/110197390.cms" target="_blank">Motorola Edge 50 Fusion vs OnePlus Nord CE 4 – price, specs and features compared</a><a href="https://www.businessinsider.in/tech/mobile/webstories/iqoo-z9x-5g-with-120hz-display-6000mah-launched-starting-at-12999/slidelist/110176453.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/mobile/webstories/iqoo-z9x-5g-with-120hz-display-6000mah-launched-starting-at-12999/slidelist/110176453.cms" target="_blank">iQOO Z9x 5G with 120Hz display, 6000mAh launched starting at ₹12,999</a><a href="https://www.businessinsider.in/india/news/woman-loses-54-lakh-in-work-from-home-scam-heres-what-it-is-and-how-to-protect-yourself/articleshow/110166963.cms" target="_blank"></a> <a href="https://www.businessinsider.in/india/news/woman-loses-54-lakh-in-work-from-home-scam-heres-what-it-is-and-how-to-protect-yourself/articleshow/110166963.cms" target="_blank">Woman loses ₹54 lakh in work-from-home scam! Here's what it is and how to protect yourself</a>

Singapore seeing new COVID-19 wave, minister advises wearing of masks

The pharmaceutical giant <keyword id="19910149" type="General" weightage="20" keywordseo="AstraZeneca" source="keywords" meta.keywordsubtype="org" meta.entityname="AstraZeneca" meta.hostid="261" meta.entityid="AstraZeneca">AstraZeneca</keyword>'s <keyword id="20040659" type="General" weightage="20" keywordseo="COVID-19-vaccine" source="keywords">COVID-19 vaccine</keyword> is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side effect, according to a report in the British Newspaper 'The Telegraph'. AstraZeneca has announced that the <keyword id="19959412" type="General" weightage="20" keywordseo="vaccine" source="keywords">vaccine</keyword> was being removed from markets for commercial reasons. It further said that the vaccine was no longer being made or supplied, having been superseded by updated vaccines that fight new variants. The application to withdraw the vaccine was made on March 5 and came into effect on May 7. The vaccine can be no longer used in the European Union following the company's decision to withdraw its "marketing authorisation." Similar applications will be submitted in the UK and other nations in the coming months that have given a go-ahead to the vaccine, known as Vaxzevria. In recent months, Vaxzevria has come under scrutiny over a very rare side effect, which causes blood clots and low blood platelet counts. In court documents, AstraZeneca in the High Court in February admitted that the vaccine "can, in very rare cases, cause <keyword id="20218859" type="General" weightage="20" keywordseo="TTS" source="keywords">TTS</keyword>". TTS which stands for <keyword id="21475609" type="General" weightage="20" keywordseo="Thrombosis-with-Thrombocytopenia-Syndrome" source="keywords">Thrombosis with Thrombocytopenia Syndrome</keyword> has been associated with at least 81 deaths in the UK and hundreds of serious injuries. More than 50 alleged victims and grieving relatives have filed a lawsuit against AstraZeneca in a High Court case. AstraZeneca has insisted that the decision to withdraw the vaccine is not related to the case or admission that it can cause TTS and termed the timing a pure coincidence, according to The Telegraph report. "We are incredibly proud of the role Vaxzevria played in ending the global pandemic. According to independent estimates, over 6.5 million lives were saved in the first year of use alone and over three billion doses were supplied globally. Our efforts have been recognised by governments around the world and are widely regarded as being a critical component of ending the global pandemic," The Telegraph quoted AstraZeneca as saying. In a statement, the pharmaceutical giant said, "As multiple, variant Covid-19 vaccines have since been developed, there is a surplus of available updated vaccines", adding that it has led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied, The Telegraph reported. It further announced its decision to initiate the withdrawal of the marketing authorisations for Vaxzevria within Europe. The company said, "We will now work with regulators and our partners to align on a clear path forward to conclude this chapter and significant contribution to the Covid-19 pandemic." Last week, AstraZeneca reiterated its commitment to patient safety while emphasising the vaccine's overall safety profile. An AstraZeneca spokesperson had stated, "Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines." This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its <keyword id="19896627" type="General" weightage="20" keywordseo="covid" source="keywords">Covid</keyword> vaccine Covishield and Vaxzevria "can, in very rare cases, cause Thrombosis Thrombocytopenia Syndrome (TTS)." Despite these rare occurrences, the pharmaceutical company maintained that extensive clinical trial data and real-world evidence consistently support the vaccine's safety and efficacy. Regulatory agencies worldwide continue to assert that the benefits of vaccination outweigh the risks of such extremely rare side effects. SEE ALSO:<a href="https://www.businessinsider.in/stock-market/webstories/aadhar-housing-finance-ipo-price-band-to-risk-factors-all-you-need-to-know/slidelist/109919298.cms" target="_blank"></a> <a href="https://www.businessinsider.in/stock-market/webstories/aadhar-housing-finance-ipo-price-band-to-risk-factors-all-you-need-to-know/slidelist/109919298.cms" target="_blank">Aadhar Housing Finance IPO – Price band to risk factors, all you need to know</a><a href="https://www.businessinsider.in/business/auto/webstories/top-selling-cars-in-india-in-april-2024-tata-punch-continues-to-dominate/slidelist/109909744.cms" target="_blank"></a> <a href="https://www.businessinsider.in/business/auto/webstories/top-selling-cars-in-india-in-april-2024-tata-punch-continues-to-dominate/slidelist/109909744.cms" target="_blank">Top-selling cars in India in April 2024 – Tata Punch continues to dominate</a><a href="https://www.businessinsider.in/tech/news/worldwide-tablet-shipments-grow-in-q1-2024-after-two-years-of-decline/articleshow/109876390.cms" target="_blank"></a> <a href="https://www.businessinsider.in/tech/news/worldwide-tablet-shipments-grow-in-q1-2024-after-two-years-of-decline/articleshow/109876390.cms" target="_blank">Worldwide tablet shipments grow in Q1 2024 after two years of decline</a>

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

<ul class="summary-list"><li>New Jersey's nursing homes are battling COVID-19 once again as new variants spread through the US.</li><li>One in every four facilities has reported an outbreak over the past week, according to state data.</li></ul>In New Jersey, elderly people are coming under threat from COVID-19 once again as new variants spread across the US.One out of every four nursing homes and assisted living facilities there reported outbreaks of the virus last week, according to <a href="https://www.state.nj.us/health/cd/documents/topics/NCOV/LTC/LTC_Facilities_Outbreaks_List.pdf?_gl=1*5fp5e2*_ga*MTY2MDI5ODQxNS4xNjkzNTg0MzUx*_ga_5PWJJG6642*MTY5MzU4NDc4My4xLjEuMTY5MzU4NTEwMC4wLjAuMA.." target="_blank" rel="noopener">state health department data</a>.The latest figures show that 158 nursing homes are battling COVID-19 outbreaks across New Jersey, leading to 1,861 cases and 15 deaths among residents and staff.On Friday, the Biden administration pledged to <a href="https://www.reuters.com/world/us/biden-seeks-minimum-staff-levels-us-nursing-homes-2023-09-01/" target="_blank" rel="noopener">bring in new laws to prevent chronic understaffing in nursing homes</a>.A fact sheet on its proposed changes said that over 200,000 nursing home residents and workers had died from COVID-19, making up about one-fifth of the US's total death toll.The spike in cases in New Jersey facilities comes with hospitalizations and deaths resulting from coronavirus ticking up nationwide.<a href="https://www.insider.com/new-covid-variant-eris-symptoms-transmission-2023-8">The Eris variant</a> has become the dominant strain, and accounts for over 20% of all US COVID-19 cases, according to the <a href="https://covid.cdc.gov/covid-data-tracker/#variant-proportions" target="_blank" rel="noopener">Centers for Disease Control</a> – although it doesn't appear to make people any sicker than other existing strains.Eris' symptoms seem similar to other variants' and include cough, shortness of breath, and fatigue.Hospitalizations from the disease rose 19% and deaths jumped 18% in the most recent weeks for which data is available, per data from the <a href="https://covid.cdc.gov/covid-data-tracker/#variant-proportions" target="_blank" rel="noopener">CDC</a>.As well as nursing homes, some education bodies have struggled to contain the spread of the virus, with <a href="https://themessenger.com/health/covid-school-closures-kentucky-scottlockard-kevinhall-lee-county-respiratory-virus" target="_blank" rel="noopener">two districts in Kentucky</a> and <a href="https://themessenger.com/health/covid-school-closures-texas-sanantonio-staff-karnes-county-classes-canceled" target="_blank" rel="noopener">one in Texas</a> shutting their schools down after a spike in cases.The CDC doesn't expect to have to reintroduce mask mandates or update vaccine programs anytime soon despite the spread of COVID-19 across the US, with the group's director saying last month that she didn't expect Eris to drive any shift in policy."What we're seeing with the changes in the viruses, they're still susceptible to our vaccine, they're still susceptible to our medicines, they're still picked up by the tests," Dr. Mandy Cohen said in an interview on former Biden administration adviser Andy Slavitt's <a href="https://omny.fm/shows/in-the-bubble/the-new-cdc-director-on-the-covid-wave-w-dr-mandy" target="_blank" rel="noopener">"In the Bubble" podcast</a> on August 9."We're seeing small changes that are what I would call subtypes of what we've seen before."

Nursing homes in New Jersey battle COVID-19 surge as hospitalizations and deaths caused by new variants jump across the US

The number of cases of COVID-19's <keyword id="15929505" type="General" weightage="20" keywordseo="XBB-1-5-variant" source="Orion">XBB.1.5 variant</keyword>, responsible for the rise in cases in the US, has gone up to 26 in India, according to INSACOG data on Monday. The cases of XBB.1.5 variant have been found across 11 states and Union territories till now, including <keyword id="66" type="General" weightage="20" keywordseo="delhi" source="Orion">Delhi</keyword>, <keyword id="13126" type="General" weightage="20" keywordseo="maharashtra" source="Orion">Maharashtra</keyword> and <keyword id="6357783" type="General" weightage="20" keywordseo="west-bengal" source="Orion">West Bengal</keyword>, the Indian SARS-CoV-2 Genomics Consortium (INSACOG) said. The XBB.1.5 strain is a relative of the <keyword id="1609796" type="General" weightage="50" keywordseo="omicron" source="Orion">Omicron</keyword> XBB variant, which is a recombinant of the Omicron BA.2.10.1 and BA.2.75 subvariants. Combined, XBB and XBB.1.5 make up 44 per cent of cases in the US. The INSACOG data also showed that 14 cases of BF.7 strain which is apparently driving China's COVID-19 wave have been found in India. There are four cases of Omicron sub-variant BF.7 reported in West Bengal, three in Maharashtra, two each in Haryana and Gujarat and one each in Odisha, Delhi and <keyword id="6354780" type="General" weightage="50" keywordseo="karnataka" source="Orion">Karnataka</keyword>. INSACOG reports genomic surveillance of SARS-CoV-2 across the country through sequencing of samples from sentinel sites and international passengers arriving in India. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/google-cci-penalty-case-will-you-put-in-same-regime-as-in-europe-sc-asks-google/articleshow/97027578.cms">Google-CCI penalty case: 'Will you put in same regime as in Europe', SC asks Google</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/thelife/personalities/news/ruchir-modi-lalit-modis-son-named-as-his-successor/slidelist/97023203.cms">The rise of the Lalit Modi heir: All about Ruchir Modi, son &amp; successor of IPL founder</a>

Covid 19's XBB.1.5 variant cases rise to 26 in India: INSACOG

No new Covid-19 variants have emerged in <keyword id="1334" type="General" weightage="100" keywordseo="china" source="Orion">China</keyword> during the recent surge in infections since the country ended its zero-Covid policy, according to an analysis of cases in <keyword id="1333" type="General" weightage="80" keywordseo="beijing" source="Orion">Beijing</keyword> published in The <keyword id="6361830" type="General" weightage="80" keywordseo="lancet" source="Orion">Lancet</keyword>. The study suggests two existing <keyword id="1609796" type="General" weightage="80" keywordseo="omicron" source="Orion">Omicron</keyword> sub-variants, BA.5.2 and BF.7, among the most dominant variants in Beijing during 2022, accounted for more than 90 per cent of local infections between November 14 and December 20, 2022. Imported cases during the same period mostly involved different variants to those dominant in Beijing. Genome analysis of 413 new Covid-19 infections in Beijing spanning the time period when China lifted its most strict pandemic control policies suggests that all were caused by existing strains. "Our analysis suggests two known Omicron sub-variants - rather than any new variants - have chiefly been responsible for the current surge in Beijing, and likely China as a whole. However, with ongoing large-scale circulation of Covid-19 in China, it is important we continue to monitor the situation closely so that any new variants that might emerge are found as early as possible," said Professor George Gao of the Institute of Microbiology at the Chinese Academy of Sciences. The results represent a snapshot of the pandemic in China, due to the characteristics of Beijing's population and the circulation of highly transmissible Covid-19 strains there. In the three years since Covid-19 was declared a global pandemic, the emergence of variants such as Alpha, Beta, Gamma, Delta, and Omicron has caused multiple waves of cases around the world. In the latest study, the authors analysed Covid-19 samples detected in Beijing in 2022. Genome sequences were generated using rapid, large-scale sequencing technology, and their evolutionary history and population dynamics analysed using existing high-quality Covid-19 sequences. Analysis of the 413 new sequences revealed they all belong to existing, known COVID-19 strains. The dominant strain in Beijing after November 14 2022 was BF.7, which accounted for 75.7 per cent of local infections. Another Omicron sub-variant, BA5.2, was responsible for 16.3 per cent of local cases. Professor Wolfgang Preiser and Dr Tongai Maponga of the University of Stellenbosch, South Africa, who were not involved in the study, said: "It is welcome to see this much-needed data from China. It is certainly reassuring that this study yielded no evidence for novel variants but not a surprise: the surge is amply explained by the abrupt cessation of effective control measures." However, they urge caution in drawing conclusions about China as a whole based on data from Beijing, saying that "the SARS-CoV-2 molecular epidemiological profile in one region of a vast and densely populated country cannot be extrapolated to the entire country". SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/auto/news/ola-launches-new-e-scooter-s1-air-starting-at-84999/articleshow/97774661.cms">Ola launches new e-scooter S1 Air, starting at ₹84,999</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/reliance-capital-case-battling-for-higher-value-to-stakeholders-says-iihl/articleshow/97776304.cms">Reliance Capital case: Battling for higher value to stakeholders says IIHL</a>

No new Covid variants emerged during China's recent outbreak: Lancet study

<ul><li><keyword id="6355882" type="General" weightage="20" keywordseo="Israel" source="Orion">Israel</keyword> reports two cases of a <keyword id="10466854" type="General" weightage="20" keywordseo="new-Covid-19-variant" source="Orion">new COVID-19 variant</keyword> on Wednesday.</li><li>The new variant identified is not worrisome as other variants, says the Health Ministry.</li><li>This new variant is the combination of two sub-variants of the Omicron strain — dubbed BA.1 and BA.2.</li></ul>Israel’s health ministry, on Wednesday, announced that it had detected two cases of a new COVID-19 variant. However, the new variant identified is not worrisome as other variants. The health ministry further informed that this new variant is the combination of two sub-variants of the Omicron strain — dubbed BA.1 and BA.2. This variant was reported in two passengers at Israel’s Ben Gurion airport while doing the PCR test. “ This variant is still unknown around the world,” said the ministry in a statement. Israel’s pandemic response chief Salman Zarka said, “The phenomenon of combined variants is well known. At this stage, we are not worried about it leading to serious cases.” “Israel will also not lift more COVID-19 restrictions amid rising infections in several locations around the world,” the Prime Minister's Office said in a statement on Thursday. Following a consultation meeting with health officials, Prime Minister Naftali Bennett and Health Minister Nitzan Horowitz decided that the mask mandate will not be lifted, but the measure will be reviewed again in April. <cmsannotation type="cmsannotation" annotationid="Symptoms of this new variant" comment="subhead" text="Symptoms of this new variant">Symptoms of this new variant</cmsannotation> Talking about the symptoms of the new variant, the ministry said the two cases suffered mild symptoms only and didn't require any special medical response. These symptoms were seen — <ol><li>Fever </li><li>Headache </li><li>Muscle dystrophy</li></ol><cmsannotation type="cmsannotation" annotationid="From where did this variant originate?" comment="subhead" text="From where did this variant originate?">From where did this variant originate?</cmsannotation> The ministry has not conducted the research yet, so it is still unknown where this variant came from. Israel has so far inoculated four million COVID-19 doses out of the population of 9.2 million people. The country also recorded 1.4 million cases of COVID-19 infection and 8,244 deaths to date. The Israeli government has administered three COVID-19 vaccines to its people and will start the fourth vaccine dose to people over 60 years and health workers. Last month, Israel also announced that unvaccinated tourists would now be allowed to enter as the country eased down the COVID restrictions. Prime Minister Naftali Bennett said that the country was seeing a ‘consistent decline in morbidity data, hence decided to reopen the border. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/paytm-may-face-tough-times-ahead-stock-brokers-recommend-to-stay-away-from-the-stock/articleshow/90283463.cms">Paytm may face ‘tough times ahead’, stock brokers recommend to stay away from the stock</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/india/news/top-10-richest-people-in-india-in-2021-22-as-per-hurun-list/slidelist/90282882.cms">Top 10 richest people in India as per Hurun List</a>

You Searched For "covid 19 variant" and got 8 results

290 cases of COVID-19 variant KP.2, 34 cases of KP.1 detected in India: INSACOG data

PTI

WHO designates Covid's BA.2.86 as 'variant under monitoring'

ANI

Singapore seeing new COVID-19 wave, minister advises wearing of masks

PTI

AstraZeneca withdraws COVID-19 vaccine worldwide, cites commercial reasons

ANI

Nursing homes in New Jersey battle COVID-19 surge as hospitalizations and deaths caused by new variants jump across the US

George Glover

Covid 19's XBB.1.5 variant cases rise to 26 in India: INSACOG

PTI

No new Covid variants emerged during China's recent outbreak: Lancet study

IANS

Israel detects new COVID-19 variant — All you need to know about it

Vaamanaa Sethi

Popular Keywords

Buying Guides